Email: cspc@cspc.cn

Contact Us
EN

News

News

Home > Media > News > "SYSH1901"Obtains Clinical Trial Approval for Covid-19

"SYSH1901"Obtains Clinical Trial Approval for Covid-19

November 23, 2022

11.png

12.png

Previous: Antibody-Drug Conjugate Cpo204 Obtains Clinical Trial Approval In The U.S.

Next: CSPC Shines at CPHI Frankfurt

Contact Us

Phone:

+86 311 8703 7015

Email:

cspc@cspc.cn

Products

Science

About Us

Legal terms Privacy protection
Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat